NEWS
Big News
(OTC: SILS) Has Acquired
AffordableTelehealthPlan
We’re thrilled to announce that Affordable Telehealth Plan has officially been acquired. The acquisition marks a major milestone in our journey to deliver affordable healthcare.
GLP-1 for the WIN
Looking to lose weight quickly?
GLP-1 like Semaglutide, approved for weight loss, are available in the market under various brand names, including Ozempic, and Wegovy have gained immense popularity among celebrities and regular individuals alike for their ability to accelerate the weight loss process and offer incredible results.
Weight loss
GLP-1 Menu
Individuals interested in starting their journey with Semaglutide can start your visit to learn whether or not they qualify based on their state, health, age and other factors. We’re offering a free initial visit and prescriptions starting at $75/week with 3 months purchase. We’re excited to help you kickstart your health journey!
Semaglutide (High-Dose)
- Up to 25% of body weight loss
- Same active ingredient as in Ozempic® and Wegovy®
- Ongoing support from our care team
Semaglutide (Low-Dose)
- Up to 25% of body weight loss
- Same active ingredient as in Ozempic® and Wegovy®
- Ongoing support from our care team
Terzepitide
- Up to 25% of body weight loss
- Same active ingredient as in Mounjaro® and Zepbound®
- Ongoing support from our care team
Invest in GLP-1 Treatment for Obesity and Related Complications
GLP-1 agonists and GIP receptors are excellent for weight loss and managing obesity, which is a complex medical condition in and of itself.
While lifestyle factors are a contributor to obesity and often a leading cause, there may also be medical causes, hormonal disruptions, and psychological factors that impact patients. In either case, obesity is not only the effect but also the cause of various health and wellness issues that require medical intervention.
That’s why GLP-1 treatments for obesity have shown additional benefits beyond weight loss. They can improve blood sugar control, lower blood pressure, and reduce the risk of cardiovascular disease. These effects make GLP-1 agonists a valuable tool in managing obesity and its associated health complications.
It’s important to note, however, that while safe and harmless on the whole, GLP-1 agonists may cause side effects, such as nausea, vomiting, and diarrhea, as the body adapts to them.
Case study
Why Medical Agents Are the Inevitable Future of Telehealth: The Rise of Self-Evolving, AI-Powered Care
This study highlights how large language model agents can revolutionize telehealth by learning autonomously in realistic medical simulations. “A Simulacrum of Hospital with Evolvable Medical Agents” introduces a fully simulated hospital environment where AI-powered agents—representing doctors, nurses, and patients—interact to replicate real-world healthcare workflows. Using a novel training method called MedAgent-Zero, doctor agents evolve through simulated experiences without the need for manually labeled data. These agents continuously improve in diagnosis, examination, and treatment tasks, eventually outperforming existing models on medical benchmarks like MedQA.